# OnCo record paper-hodi-ipilimumab-melanoma-nejm-2010 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-hodi-ipilimumab-melanoma-nejm-2010" ;
schema:name "Hodi 2010: ipilimumab, the first checkpoint inhibitor, extends survival in metastatic melanoma"@en ;
schema:description "Blocking the immune brake CTLA-4 was the first treatment ever to prolong life in metastatic melanoma, with about one in five patients alive at two years and a new class of autoimmune side effects."@en ;
schema:url ;
schema:dateModified "2026-09-08"^^xsd:date ;
schema:citation , ;
schema:sameAs ;
schema:datePublished "2010"^^xsd:gYear ;
schema:author "Hodi FS, O'Day SJ, McDermott DF, et al." ;
onco:related , ;
onco:cancers ;
onco:technologies ;
onco:targets ;
onco:drugs ;
onco:companies ;
onco:institutions ;
onco:terms , ;
onco:people , , ;
onco:bottlenecks , ;
onco:journals .